Waters Corporation has unveiled new instruments, software and product enhancements to drive drug discovery and development at the American Society for Mass Spectrometry 2022 Annual Conference.

Thermo Fisher Scientific Inc. has released new software to scientists in biopharmaceutical, proteomics and small molecule settings to enable more comprehensive analysis of their data.

Thermo Fisher Scientific Inc. is providing proteomics and biopharmaceutical research laboratories with a new micro-pillar array column as part of an end-to-end LC-MS workflow that will simplify complex bottom-up proteomics analyses.

Thermo Fisher Scientific Inc. is providing forensic toxicologists, clinical research toxicologists, employee drug testing facilities and wellness organizations with an all-in-one liquid chromatography-mass spectrometry (LC-MS) toxicology solution to keep pace with the ever-changing landscape of emerging and illicit drugs.

Thermo Fisher Scientific Inc. is helping proteomics researchers increase productivity and free up time for more value-added activities when generating high quality samples for analysis, using a new automated sample preparation system that integrates within any LC-MS workflow.

Thermo Fisher Scientific Inc. is providing proteomics and biopharmaceutical laboratories working in drug discovery and R&D applications with an innovative mass spectrometry solution that, for the first time, unlocks the ability to clearly decipher complex mixtures of large macromolecules.

Thermo Fisher Scientific announces the winners of the 2022 Thermo Scientific Tandem Mass Tag (TMT) Research Award.

Thermo Fisher Scientific Inc. and TransMIT GmbH Center for Mass Spectrometric Developments have announced a co-marketing agreement to promote the use of a mass spectrometry imaging (MSI) platform for spatial multi-omics applications in pharma and clinical labs.

Thermo Fisher Scientific Inc. is showcasing new instruments, workflows, software and industry collaborations that enable customers to generate new analytical insights and accelerate next generation vaccine and therapy development.

Today at the Advances in Genome Biology and Technology (AGBT) Conference, DNA Script announced the launch of the industry’s first solution to enable same-day turnaround for custom q/dPCR assays with a new generation of kits for the SYNTAX System to print both primers and probes in hours.